ATE526963T1 - Pharmazeutische zusammensetzung mit olmesartan- medoxomil - Google Patents

Pharmazeutische zusammensetzung mit olmesartan- medoxomil

Info

Publication number
ATE526963T1
ATE526963T1 AT06009223T AT06009223T ATE526963T1 AT E526963 T1 ATE526963 T1 AT E526963T1 AT 06009223 T AT06009223 T AT 06009223T AT 06009223 T AT06009223 T AT 06009223T AT E526963 T1 ATE526963 T1 AT E526963T1
Authority
AT
Austria
Prior art keywords
medoxomil
pharmaceutical composition
composition containing
containing olmesartan
olmesartan
Prior art date
Application number
AT06009223T
Other languages
English (en)
Inventor
Matej Avanzo
Peterka Tanja Rozman
Igor Legen
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE526963T1 publication Critical patent/ATE526963T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06009223T 2006-05-04 2006-05-04 Pharmazeutische zusammensetzung mit olmesartan- medoxomil ATE526963T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06009223A EP1891952B1 (de) 2006-05-04 2006-05-04 Pharmazeutische Zusammensetzung mit Olmesartan-Medoxomil

Publications (1)

Publication Number Publication Date
ATE526963T1 true ATE526963T1 (de) 2011-10-15

Family

ID=37076372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06009223T ATE526963T1 (de) 2006-05-04 2006-05-04 Pharmazeutische zusammensetzung mit olmesartan- medoxomil

Country Status (8)

Country Link
US (1) US9707178B2 (de)
EP (2) EP1891952B1 (de)
AT (1) ATE526963T1 (de)
CA (1) CA2651138C (de)
ES (1) ES2388880T3 (de)
PL (1) PL2021002T3 (de)
SI (2) SI1891952T1 (de)
WO (1) WO2007128478A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033643A4 (de) 2006-06-27 2013-01-02 Daiichi Sankyo Co Ltd Komprimierte zubereitung
EP2228066A1 (de) * 2009-03-03 2010-09-15 LEK Pharmaceuticals d.d. Pharmazeutische Zusammensetzungen eines auf Sulphonylharnstoff basierenden pharmazeutischen Wirkstoffs mit ausgezeichneten Auflösungseigenschaften
WO2011045760A2 (en) * 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Micronized olmesartan medoxomil compositions
WO2011083112A2 (en) 2010-01-05 2011-07-14 Ratiopharm Gmbh Solid oral dosage form containing olmesartan medoxomil
TR201005867A1 (tr) 2010-07-16 2012-02-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Olmesartan farmasötik bileşimleri.
JP5705562B2 (ja) * 2011-01-25 2015-04-22 沢井製薬株式会社 カンデサルタンシレキセチル含有錠剤及びその製造方法
WO2014002011A1 (en) * 2012-06-26 2014-01-03 Micro Labs Limited Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof
WO2014188729A1 (ja) * 2013-05-24 2014-11-27 持田製薬株式会社 経口用組成物
JP6653116B2 (ja) * 2014-08-27 2020-02-26 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤
JP6765473B2 (ja) * 2019-05-09 2020-10-07 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IE920540A1 (en) 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
EP1262180A4 (de) * 2000-02-18 2005-06-01 Takeda Pharmaceutical Tnf-alpha hemmer
EP1595540A1 (de) * 2000-11-21 2005-11-16 Sankyo Company Limited Zusammensetzung enthaltend einen Angiotensin-II-Rezeptor-Antagonist und einen Diuretikum und deren Verwendung zur Behandlung von Bluthochdruck
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
GB0325291D0 (en) * 2003-10-29 2003-12-03 Pfizer Ltd Novel combination
RU2384346C2 (ru) * 2004-06-23 2010-03-20 Зольвай Фармасьютиклз Гмбх Фармацевтические композиции, содержащие nep-ингибиторы, ингибиторы эндогенной эндотелинпродуцирующей системы и антагонисты at1-рецептора
US20060074117A1 (en) * 2004-09-02 2006-04-06 Lilach Hedvati Purification of olmesartan medoxomil
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CA2585030A1 (en) * 2004-10-27 2006-05-04 F. Hoffmann-La Roche Ag New indole or benzimidazole derivatives
US20060281800A1 (en) * 2005-04-12 2006-12-14 Glenmark Pharmaceuticals Limited Polymorphic form of olmesartan and process for its preparation
CA2616466A1 (en) * 2005-07-29 2007-02-15 Krka Process for the preparation of olmesartan medoxomil

Also Published As

Publication number Publication date
EP1891952B1 (de) 2011-10-05
EP1891952A1 (de) 2008-02-27
WO2007128478A3 (en) 2008-02-07
WO2007128478A2 (en) 2007-11-15
PL2021002T3 (pl) 2012-11-30
US20090238871A1 (en) 2009-09-24
ES2388880T3 (es) 2012-10-19
SI2021002T1 (sl) 2012-10-30
EP2021002B1 (de) 2012-05-30
CA2651138A1 (en) 2007-11-15
SI1891952T1 (sl) 2012-02-29
US9707178B2 (en) 2017-07-18
EP2021002A2 (de) 2009-02-11
CA2651138C (en) 2016-02-16

Similar Documents

Publication Publication Date Title
PL2021002T3 (pl) Kompozycja farmaceutyczna zawierająca medoksomil olmesartanu
ATE499090T1 (de) Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan
EA201070698A1 (ru) Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
UY28756A1 (es) Compuestos
ATE459622T1 (de) Tropanverbindungen
BR122013025375B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
UY28755A1 (es) Compuestos
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
UY30316A1 (es) Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones
ECSP088871A (es) Derivados de triazolopirazina
UY30610A1 (es) Moduladores de mglur5
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
MX2010002584A (es) Derivados de piperidina como agonistas de receptores muscarinicos.
CR11251A (es) Depsipeptidos ciclicos y usos de los mismos
BR112012011328A2 (pt) inibidores de akt
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
UY30393A1 (es) Derivados sustituidos de la 1-piperidin-1-il-1,3-dihidro-2h-benzimidazol-2-ona, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
CO6321158A2 (es) Formulacion oral
CR20110209A (es) Composición farmacéutica sólida
SV2010003723A (es) Derivados de piperidina 3,4-sustituida como inhibidores de renina
UY30363A1 (es) Derivados sustituidos de la n-(3-oxo-2,3-dihidro-1h-isoindol-4-il)-1-naftamida, procesos de preparacion, composiciones farmacéuticas y aplicaciones
NO20085317L (no) Imidazoazepinonforbindelser
UY29486A1 (es) Compuestos utiles en terapia
ATE400257T1 (de) Stabile pharmazeutische zusammensetzung mit linezolid form iv
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties